"The active substances present in African medicinal plants may be capable of killing off tumour cells that are resistant to more than one drug," said Professor Thomas Efferth from the Johannes Gutenberg University Mainz.
"They thus represent an excellent starting point for the development of new therapeutic treatments for cancers that do not respond to conventional chemotherapy regimens," he said.
Efferth and biochemist Dr Victor Keute of the University of Dschang in Cameroon have been studying the active substances in African plants such as the giant globe thistle, wild pepper, speargrass, and Ethiopian pepper.
During the joint project with Mainz, the Cameroonian scientist Victor Kuete has examined more than 100 spices and plants from his homeland for their cytotoxic effects on cancer cells.
"We have already found an entire series of benzophenones and other phytochemicals that are able to elude resistance mechanisms and thus offer many new opportunities for continued research," said Efferth.
The researchers are focusing on three different resistance mechanisms. Transporter-mediated resistance prevents drugs taking effect because a substance called P-glycoprotein promotes their efflux from cancer cells.
Lastly, in oncogene-mediated resistance, the epidermal growth factor receptor (EGFR) sends signals into the interior of cells causing tumors to grow faster.
The researchers in Mainz have cellular models of all three resistance mechanisms that will enable them to appropriately test the effectiveness of the substances obtained from plants.
In their latest of a total of eight publications produced to date, the research team reports that four naturally occurring benzophenones can prevent the proliferation of the tested cancer cell lines, including multi-drug resistant strains.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
